Sign in
Enrolling by invitationPhase 3

Extended use of aroxybutynin and atomoxetine for obstructive sleep apnea

Tests aroxybutynin and atomoxetine in adults with obstructive sleep apnea after earlier studies.

Key facts

Who runs it
Apnimed
Where
Abington, Albuquerque, Anaheim, Ann Arbor, Atlanta, Austin, Birmingham, Brandon, Canton, Cerritos, Chandler, Charleston, Chattanooga, Chesterfield, Chicago, Chula Vista, Cincinnati, Clearwater, Columbia, Cutler Bay, Dallas, Daytona Beach, Decatur, Denver, Eatontown, Fargo, Gastonia, Glen Burnie, Greenville, Hazelwood, Henderson, High Point, Houston, Huntersville, Huntsville, Kansas City, Lake Worth, Lathrup Village, Lehigh Acres, Little Rock, Los Alamitos, Los Angeles, Louisville, Memphis, Meridian, Mesa, Miami, Neptune City, New Bern, New Hyde Park, Newton, North Dartmouth, North Las Vegas, Novi, Ocala, Orlando, Phoenix, Pomona, Portland, Riverside, Rock Hill, Rockville, San Antonio, San Diego, San Ramon, Santa Ana, South Ogden, Springfield, St Louis, Sterling Heights, Suwanee, Tampa, Tempe, Tucson, Tuscaloosa, Valdosta, Vienna, West Covina, West Palm Beach, Wilmington, Winter Park, and Wyomissing, United StatesSee the 93 sitesAlso in 1 other country, 6 sites
Trial code
Registry title
Continuation Protocol for Obstructive Sleep Apnea (OSA)
Status
Enrolling by invitation
Phase
Phase 3
People taking part
1,280 people, planned
Started
3 Jul 2024
Planned end
30 Jun 2026
Type of study
Interventional
Treatments tested
  • Aroxybutynin and Atomoxetine
Record updated
13 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obstructive sleep apnea who completed one of two earlier AD109 studies, APC-APN-304 or APC-APN-305. Everyone gets AD109 (aroxybutynin and atomoxetine) openly.

Age
18 Years and older
Sex
All
Disease stage
Obstructive sleep apnea (OSA).
Earlier treatment
People must have completed study APC-APN-304 or APC-APN-305 without stopping the study drug for good.

Main reasons for not taking part

  • The study doctor thinks taking part would be unsafe because of the person's current health.
  • The study doctor thinks taking part would be unsafe because of other treatments the person takes.

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Completion of APC-APN-304 without permanent discontinuation of IMP
  • Completion of APC-APN-305 without permanent discontinuation of IMP

Who cannot take part

  • Participants are excluded from the study if participation would be considered unsafe by the investigator based on concomitant therapies
  • Participants are excluded from the study if participation would be considered unsafe by the investigator based on the individual's current status

Where in United States

Also in 1 other country, 6 sites

  • Abington Neurological AssociatesAbington, United StatesEnrolling by invitation
  • Maimonides Sleep Arts & SciencesAlbuquerque, United StatesEnrolling by invitation
  • Orange County Research InstituteAnaheim, United StatesEnrolling by invitation
  • University of Michigan Clinical Research UnitAnn Arbor, United StatesEnrolling by invitation
  • Atlanta Center for Medical ResearchAtlanta, United StatesEnrolling by invitation
  • NeuroTrials Research IncAtlanta, United StatesEnrolling by invitation
  • FutureSearch Trials of NeurologyAustin, United StatesEnrolling by invitation
  • Sleep Disorders Center of AmericaBirmingham, United StatesEnrolling by invitation
  • Meris Clinical ResearchBrandon, United StatesEnrolling by invitation
  • Teradan Clinical TrialsBrandon, United StatesEnrolling by invitation
  • NeuroScience Research Center LLCCanton, United StatesEnrolling by invitation
  • Core Healthcare GroupCerritos, United StatesEnrolling by invitation
  • Chandler Clinical TrialsChandler, United StatesEnrolling by invitation
  • Lowcountry Lung and Critical Care, PACharleston, United StatesEnrolling by invitation
  • Chattanooga Research & MedicineChattanooga, United StatesEnrolling by invitation
  • Sleep Medicine and Research Center, St. Luke's HospitalChesterfield, United StatesEnrolling by invitation
  • Chicago Research Center Inc.Chicago, United StatesEnrolling by invitation
  • Exalt Clinical Research IncChula Vista, United StatesEnrolling by invitation
  • CTI Clinical Research CenterCincinnati, United StatesEnrolling by invitation
  • Intrepid Research, LLCCincinnati, United StatesEnrolling by invitation
  • St Francis Medical InstituteClearwater, United StatesEnrolling by invitation
  • Centennial Medical Group Research DepartmentColumbia, United StatesEnrolling by invitation
  • Nouvelle Clinical ResearchCutler Bay, United StatesEnrolling by invitation
  • FutureSearch Trials of DallasDallas, United StatesEnrolling by invitation
  • Arrow Clinical TrialsDaytona Beach, United StatesEnrolling by invitation
  • CenExel iResearch, LLCDecatur, United StatesEnrolling by invitation
  • Mountain View Clinical Research, IncDenver, United StatesEnrolling by invitation
  • Research Carolina EliteDenver, United StatesEnrolling by invitation
  • Clinilabs Drug Development CorporationEatontown, United StatesEnrolling by invitation
  • Lillestol ResearchFargo, United StatesEnrolling by invitation
  • Clinical Research of GastoniaGastonia, United StatesEnrolling by invitation
  • Sleep Disorders Centers of the Mid-AtlanticGlen Burnie, United StatesEnrolling by invitation
  • Tribe Clinical Research LLCGreenville, United StatesEnrolling by invitation
  • Velocity Clinical Research - GreenvilleGreenville, United StatesEnrolling by invitation
  • Healthcare Research NetworkHazelwood, United StatesEnrolling by invitation
  • Henderson Clinical TrialsHenderson, United StatesEnrolling by invitation
  • Peters Medical Research, LLCHigh Point, United StatesEnrolling by invitation
  • Houston Clinical Research AssociatesHouston, United StatesEnrolling by invitation
  • Memorial Hermann VillageHouston, United StatesEnrolling by invitation
  • Advanced Respiratory and Sleep MedicineHuntersville, United StatesEnrolling by invitation
  • Huntsville Research InstituteHuntsville, United StatesEnrolling by invitation
  • University of Kansas Medical CenterKansas City, United StatesEnrolling by invitation
  • Canvas Clinical ResearchLake Worth, United StatesEnrolling by invitation
  • Revive Research Institute, Inc.Lathrup Village, United StatesEnrolling by invitation
  • Florida Lung & Sleep AssociatesLehigh Acres, United StatesEnrolling by invitation
  • Preferred Research Partners, IncLittle Rock, United StatesEnrolling by invitation
  • Collaborative Neuroscience Research, LLCLos Alamitos, United StatesEnrolling by invitation
  • Santa Monica Clinical TrialsLos Angeles, United StatesEnrolling by invitation
  • Advanced ENT and AllergyLouisville, United StatesEnrolling by invitation
  • Clinical Neuroscience Solutions, Inc.Memphis, United StatesEnrolling by invitation
  • St. Luke's Idaho Pulmonary Associates - Meridian ClinicMeridian, United StatesEnrolling by invitation
  • Desert Clinical Reserach, LLC/CCT ResearchMesa, United StatesEnrolling by invitation
  • Advanced Medical Research InstituteMiami, United StatesEnrolling by invitation
  • Flourish ResearchMiami, United StatesEnrolling by invitation
  • Ivetmar Medical Group, LLCMiami, United StatesEnrolling by invitation
  • PharmaDev Clinical Research Institute, LLCMiami, United StatesEnrolling by invitation
  • Sleep DynamicsNeptune City, United StatesEnrolling by invitation
  • Coastal Carolina Health Care, P.A. Pulmonary and Sleep MedicineNew Bern, United StatesEnrolling by invitation
  • Northwell HealthNew Hyde Park, United StatesEnrolling by invitation
  • Neurocare, Inc.Newton, United StatesEnrolling by invitation
  • Infinity Medical ResearchNorth Dartmouth, United StatesEnrolling by invitation
  • Las Vegas Clinical Trials, LLCNorth Las Vegas, United StatesEnrolling by invitation
  • Henry Ford Medical Center-ColumbusNovi, United StatesEnrolling by invitation
  • Renstar Medical ResearchOcala, United StatesEnrolling by invitation
  • Clinical Neuroscience Solutions, Inc.Orlando, United StatesEnrolling by invitation
  • Foothills Research Center Cct ResearchPhoenix, United StatesEnrolling by invitation
  • Empire Clinical ResearchPomona, United StatesEnrolling by invitation
  • Northwest Research CenterPortland, United StatesEnrolling by invitation
  • Probe Clinical Research CorporationRiverside, United StatesEnrolling by invitation
  • Onsite Clinical Solutions, LLCRock Hill, United StatesEnrolling by invitation
  • Velocity Clinical ResearchRockville, United StatesEnrolling by invitation
  • Element Research GroupSan Antonio, United StatesEnrolling by invitation
  • Sleep Therapy and Research CenterSan Antonio, United StatesEnrolling by invitation
  • Pacific Research NetworkSan Diego, United StatesEnrolling by invitation
  • TriValley Sleep CenterSan Ramon, United StatesEnrolling by invitation
  • SDS Clinical Trials, Inc.Santa Ana, United StatesEnrolling by invitation
  • South Ogden Family Medicine/CCT ResearchSouth Ogden, United StatesEnrolling by invitation
  • Baystate Clinical Trials UnitSpringfield, United StatesEnrolling by invitation
  • Clayton Sleep Institute, LLCSt Louis, United StatesEnrolling by invitation
  • Clinical Neurophysiology Services PCSterling Heights, United StatesEnrolling by invitation
  • Georgia Neurology and Sleep Medicine AssociatesSuwanee, United StatesEnrolling by invitation
  • JSV Clinical Research Study IncTampa, United StatesEnrolling by invitation
  • Fiel Family and Sports Medicine/CCT ResearchTempe, United StatesEnrolling by invitation
  • Noble Clinical ResearchTucson, United StatesEnrolling by invitation
  • The University of Alabama/Institute for Rural Health ResearchTuscaloosa, United StatesEnrolling by invitation
  • Medster ResearchValdosta, United StatesEnrolling by invitation
  • Sleep Disorder Center of the Mid-AtlanticVienna, United StatesEnrolling by invitation
  • Providere Research IncWest Covina, United StatesEnrolling by invitation
  • Palm Beach Research CenterWest Palm Beach, United StatesEnrolling by invitation
  • AccellacareWilmington, United StatesEnrolling by invitation
  • Central Florida Pediatric Sleep Disorders d/b/a Florida Pediatric Institute, LLCWinter Park, United StatesEnrolling by invitation
  • Clinical Site Partners, LLC dba Flourish ResearchWinter Park, United StatesEnrolling by invitation
  • Respiratory SpecialistsWyomissing, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep apnea (OSA). The present study is a Phase 3 open label continuation protocol enrolling qualifying participants who completed one of the parent Phase 3 double-blind placebo-controlled studies, APC-APN-304 or APC-APN-305.

The group in the trial

  • AD109Treatment being tested

    Open Label AD109

    Treatment: Aroxybutynin and Atomoxetine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Phase 3 Open Label Continuation Protocol of a Fixed Dose Combination of Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea
Plain-language title
Extended use of aroxybutynin and atomoxetine for obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
13 May 2025